APA

Ma B. B. Y., Lui V. W. Y., Hui C. W. C., Lau C. P. Y., Wong C. H., Hui E. P., Ng M. H. L., Cheng S. H., Tsao S. W., Tsang C., Cheung C. S. F., Ho K. & Chan A. T. C. (20140220). Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models. : Cancer letters.

Chicago

Ma Brigette B Y, Lui Vivian W Y, Hui Connie W C, Lau Cecilia P Y, Wong Chi H, Hui Edwin P, Ng Margaret H L, Cheng Suk H, Tsao Sai W, Tsang Chi-Man, Cheung Crystal S F, Ho Kakiu and Chan Anthony T C. 20140220. Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models. : Cancer letters.

Harvard

Ma B. B. Y., Lui V. W. Y., Hui C. W. C., Lau C. P. Y., Wong C. H., Hui E. P., Ng M. H. L., Cheng S. H., Tsao S. W., Tsang C., Cheung C. S. F., Ho K. and Chan A. T. C. (20140220). Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models. : Cancer letters.

MLA

Ma Brigette B Y, Lui Vivian W Y, Hui Connie W C, Lau Cecilia P Y, Wong Chi H, Hui Edwin P, Ng Margaret H L, Cheng Suk H, Tsao Sai W, Tsang Chi-Man, Cheung Crystal S F, Ho Kakiu and Chan Anthony T C. Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models. : Cancer letters. 20140220.